Funding 21.11.2023Nice & Green, the Swiss investment firm, announces today a … Nice & Green Renews Commitment to Oryzon Genomics with Up to EUR 45 million in New FundingRead more
Funding 05.07.2022Nice & Green provides funding of €20 million to Oryzon for executing clinical trials in oncology and CNSRead more
